OTCMKTS:IRCLF InterCure (IRCLF) Stock Price, News & Analysis → America’s worst nightmare? (From Porter & Company) (Ad) Free IRCLF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$6.18▼$6.1852-Week Range N/AVolume9,400 shsAverage Volume9,097 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get InterCure alerts: Email Address Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. About InterCureInterCure Ltd, together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.Read More Ad Banyan Hill PublishingTrump’s Former Wingman Bets Big on AIOne of his AI company’s earliest investors was the CIA’s venture capital arm called In-Q-Tel … named after Q, the fictional character who makes gadgets for James Bond. Soon, an alphabet soup of 30 government agencies would entrust the company with their most sensitive information.Get the full story here. IRCLF Stock News HeadlinesApril 22, 2024 | seekingalpha.comInterCure: Bargain Israel Cannabis PlayApril 1, 2024 | finance.yahoo.comInterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 millionJanuary 31, 2024 | finance.yahoo.comInterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy ChainJanuary 21, 2024 | benzinga.comMIke TysonOctober 31, 2023 | benzinga.comInterCure Wins Cannolam Arbitration ProceedingOctober 17, 2023 | stockhouse.comInterCure Provides an Update Regarding the Security Situation in IsraelJuly 12, 2023 | marketwatch.comInterCure Plans to Delist From Toronto Stock ExchangeJune 16, 2023 | benzinga.comMedical cannabis company Better is suing InterCure and its Chairman Ehud BarakJune 9, 2023 | benzinga.comInterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed MergerMay 16, 2023 | msn.comBoxing legend Mike Tyson launches partnership with Israeli medical marijuana company InterCure: 'Very lucky'May 15, 2023 | finance.yahoo.comInterCure to Participate in the Cowen 3rd Annual European Cannabis ConferenceMay 15, 2023 | finance.yahoo.comInterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox BusinessApril 20, 2023 | msn.comInterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU CountriesApril 8, 2023 | seekingalpha.comInterCure: How Bright Is The Company's Future In 2023January 23, 2023 | finance.yahoo.comInterCure Ltd. (INCR) Stock Historical Prices & Data - Yahoo FinanceJanuary 20, 2023 | seekingalpha.comInterCure: Why The Company Is Grossly Undervalued By Wall StreetDecember 22, 2022 | reuters.comINCRU.TO - InterCure Ltd | Stock Price & Latest News | ReutersDecember 8, 2022 | benzinga.comInterCure to Participate in Cowen 5th Annual Cannabis ConferenceNovember 15, 2022 | finanznachrichten.deInterCure Ltd.: InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growthNovember 11, 2022 | finance.yahoo.comInterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoYSeptember 21, 2022 | reuters.comINCR.TA - InterCure Ltd | Stock Price & Latest News | ReutersJuly 18, 2022 | finance.yahoo.comClever Leaves Announces First Export to Israeli Partner InterCureMay 19, 2022 | msn.comInterCure (Class A) (INCR) Q1 2022 Earnings Call TranscriptMay 16, 2022 | seekingalpha.comInterCure reports Q1 resultsApril 6, 2022 | seekingalpha.comInterCure reports Q4 resultsSee More Headlines Receive IRCLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:IRCLF CUSIPN/A CIKN/A Webwww.intercure.co Phone972 7 7460 5012FaxN/AEmployees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Alexander Rabinowitz (Age 50)CEO & Director Mr. Amos CohenChief Financial OfficerMr. Omri BatzirCorp. ControllerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors IRCLF Stock Analysis - Frequently Asked Questions How do I buy shares of InterCure? Shares of IRCLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IRCLF) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishingis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InterCure Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
